Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
Liviana Da Dalt , Arianna Calistri, Chiara Chillemi, Riccardo Cusinato, Elisa Franchin, Cristiano Salata, Dino Sgarabotto, Giuseppe Toscano, Antonio Gambino, and Giorgio Palù
Author affiliations: University of Padova, Padova, Italy (L. Da Dalt, A. Calistri, C. Chillemi, E. Franchin, C. Salata, G. Palù); and; Azienda Ospedaliera di Padova, Padova (R. Cusinato, E. Franchin, D. Sgarabotto, G. Toscano, A. Gambino)
Figure. Schematic showing events surrounding oseltamivir-resistant pandemic (H1N1) 2009 virus infection in 3-year-old immunocrompromised child, Italy, in relation to viremia levels, expressed as relative units of influenza A RNA, normalized with respect to the housekeeping gene RNaseP.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.